Delivery Order SPE2DB24D2106-SPE2DB25FAVLH
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $9.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, received a delivery order valued at $23.5K from the Defense Logistics Agency (DLA) on June 16, 2025, for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This firm fixed-price delivery order, with an ultimate completion date of June 17, 2025, was awarded without set-aside designation and will be performed in Conshohocken, Pennsylvania. The award falls under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $19,259.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose-2 pen/ml pharmaceutical products. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, does not utilize a set-aside designation. Performance will be executed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- On August 20, 2025, the Defense Logistics Agency awarded a delivery order valued at $10,461.10 to DMS Pharmaceutical Group Inc. for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract does not utilize a set-aside designation, and the pharmaceutical products will be...
- The Defense Logistics Agency (DLA) awarded a $5,015.29 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300mg dose injections. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a single-unit pharmaceutical procurement with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $50,400.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300 mg pre-filled pens. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a $16.8K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300 mg pen injections. The order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and valid through November...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.08 to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300 mg pen 2 ml on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a specific pharmaceutical requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $13,735.58 to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a pharmaceutical supply requirement with performance taking place in Conshohocken, Pennsylvania. The award was made without set-aside designation to DMS Pharmaceutical Group, a woman-owned small business...
- The Defense Logistics Agency awarded a $8,935.09 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation on September 8, 2025, with an ultimate completion date of September 9, 2025. This award carries no set-aside designation and represents performance at the vendor's location in Conshohocken, Pennsylvania. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,169.67 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order covers the supply of Cosentyx (secukinumab) 300mg dose in 2-pen packages, with performance to be executed in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, allowing the...